Various laboratory protocols for measuring thromboxane A2 generation to detect the effectiveness of acetylsalicylic acid therapy: a comparative study

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
Marcin RozalskiJacek Golanski

Abstract

A reliable and simple laboratory assay for predicting clinical effectiveness of antiplatelet acetylsalicylic acid (ASA) therapy is needed. We have compared various laboratory protocols for measuring blood thromboxane A2 (TXA2) generation used to detect the effects of ASA administration. Healthy volunteers (n = 15) were given 150 mg per day ASA for 10 days, followed by ASA at 75 mg per day for 10 days. Five protocols tested for measuring TXA2 generation were: baseline TXB2 determination in plasma; static generation of TXA2 in anticoagulated blood (1 h incubation at room temperature or 37°C, respectively); dynamic generation of TXA2 in anticoagulated blood (1 h in rotary mixer); and generation of TXA2 in blood without anticoagulant (serum-generated TXA2). Platelet aggregation in whole blood was also measured using arachidonic acid (AA), collagen, and ADP as agonists. All five protocols showed significant reduction in TXB2 levels in individuals taking ASA. However, only the assay of TXA2 generation in serum was significantly different compared with the other protocols (P < 0.002). Moreover, the strongest and most significant correlation was observed between TXA2 generation in serum and AA-induced aggregation parameters (for 75 mg ...Continue Reading

References

Nov 10, 2004·Circulation·Alan D Michelson
Dec 2, 2006·Thrombosis and Haemostasis·Orsolya TóthWolfgang Siess
Jan 19, 2008·BMJ : British Medical Journal·George KrasopoulosMichael R Buchanan
Feb 5, 2008·International Journal of Cardiology·Francesco SofiGian Franco Gensini
May 20, 2008·Clinical Cardiology·Eugene BraunwaldStephen Wiviott
May 20, 2008·Clinical Cardiology·Eugene BraunwaldStephen Wiviott
Nov 20, 2008·International Journal of Laboratory Hematology·K E KimJ Y Han
Feb 16, 2010·Clinical Cardiology·Alp AydinalpHaldun Muderrisoglu
May 23, 2012·International Journal of Laboratory Hematology·M VidaliP Pergolini
Nov 6, 2012·Journal of Clinical Pharmacy and Therapeutics·M M SalamaL A ElSafady

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.